Barclays 2005 Annual Report Download - page 46

Barclays PLC
Annual Report 2005
44
Corporate governance
Barclays report on remuneration
Directors: interests in ordinary shares of Barclays PLC(a)
At 1st January 2005(b) At 31st December 2005
Non- Non-
Beneficial beneficial Beneficial beneficial
Chairman
Matthew W Barrett 289,242 – 302,264 –
Executive Directors
John Varley(c) 338,451 – 360,049 –
Robert E Diamond Jr(c)(d)(h) 1,357,318 – 1,512,575 –
Gary Hoffman(c) 161,253 – 172,702 –
Naguib Kheraj(g) 2,238 – 8,550 –
David Roberts(c)(g) 67,405 – 78,191 –
Non-executive Directors(c)
Sir David Arculus 17,428 – 19,770 –
Sir Richard Broadbent 3,992 – 6,068 –
Leigh Clifford 2,000 – 3,460 –
Dr Danie Cronjé(e)(g) ––2,000 –
Professor Dame Sandra Dawson 5,460 – 7,822 –
Sir Andrew Likierman 2,000 – 3,628 –
Sir Nigel Rudd 14,367 – 16,788 –
Stephen Russell 13,774 – 16,221 –
Robert Steel(f ) ––100,321 –
John Sunderland(f ) 8,000 – 8,308 –
Notes
(a) Beneficial interests in the table above represent shares held by Directors who were on the Board as at 31st December 2005, either directly or through a nominee,
their spouse and children under 18. They include any interests held through Sharepurchase, but do not include any awards under ESAS, ISOP, PSP, ESOS and
Sharesave schemes. At 31st December 2005, Matthew W Barrett and the executive Directors, together with other senior executives, were potential beneficiaries in
respect of a total of 147,145,847 Barclays PLC ordinary shares (1st January 2005: 115,031,594) held by the trustees of the Barclays Group Employees’ Benefit Trusts.
At 28th February 2006, a total of 156,556,203 shares were held by the trustees.
(b) Or date appointed to the Board if later.
(c) Between 31st December 2005 and 28th February 2006, John Varley, Gary Hoffman and David Roberts each purchased 40 ordinary shares through Sharepurchase.
On 10th January 2006 Gary Hoffman acquired a further 1,008 ordinary shares as a result of an option exercise on 23rd December 2005 under the Sharesave Plan.
On 21st February 2006, the non-executive Directors acquired ordinary shares pursuant to arrangements under which part of each Director’s fee is used to buy shares
in Barclays. Ordinary shares were acquired by each non-executive Director as follows: Sir David Arculus – 1,084; Sir Richard Broadbent – 946; Leigh Clifford – 864;
Dr Danie Cronjé – 669; Professor Dame Sandra Dawson – 983; Sir Andrew Likierman – 926; Sir Nigel Rudd – 1,083; Stephen Russell – 1,060; Robert Steel – 811;
John Sunderland – 882. On 28th February 2006, Robert E Diamond Jr acquired 187,957 ordinary shares following the release of a provisional allocation made
under ESAS. Except as described in this note, there were no changes to the beneficial or non-beneficial interests of Directors in the period 31st December 2005
to 28th February 2006.
(d) Appointed to the Board 1st June 2005.
(e) Appointed a non-executive Director 1st September 2005.
(f) Appointed a non-executive Director 1st June 2005.
(g) As at 1st September 2005, Dr Danie Cronjé also held 101,577 shares in Absa Group Limited. As at their date of appointment to the Board of Absa Group Limited
(27th July 2005), Naguib Kheraj and David Roberts held no shares in Absa Group Limited. As at 31st December 2005, Naguib Kheraj, David Roberts and Dr Danie
Cronjé held 1,200, 1,200 and 101,577 shares in Absa Group Limited, respectively.
(h) As at 1st June 2005, Robert E Diamond Jr also held 100,000 ‘A’ ordinary shares in Barclays Global Investors UK Holdings Limited, which shares were also held as at
31st December 2005.